Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer

logo
Natco Pharma Ltd.
09 Apr 2018
883.65
0.10%

Natco Pharma

Geojit BNP Paribas
NATCO Pharma (NATCO) is a R&D; focussed, vertically integrated pharmaceutical company with an experienced management team and presence across multiple speciality therapeutic segments. High emphasis on R&D; and complex molecules focusing on long...
Number of FII/FPI investors decreased from 317 to 235 in Sep 2025 qtr
More from Natco Pharma Ltd.
Recommended